Oruka Therapeutics, a leading biotechnology firm specializing in innovative biologics for chronic skin disease treatment, is set to make waves by joining the esteemed Nasdaq
Category: News
Is This the Game Changer for Zevra Therapeutics? Big News Ahead
Transformational Opportunity on the Horizon Zevra Therapeutics (ZVRA) is set to join the prestigious Nasdaq Biotechnology Index (NBI) beginning December 23, 2024. This milestone marks